|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pemetrexed: biochemical and celtular pharmacology, mechanisms, and clinical applications显示文摘 | Chattopadhyay S Moran RG Goldman ID | 2007 | Mol Cancer Ther2007，6，2： | 1 |
| 2 | Pemmetrexed:biochemical and celluar pharmacology mechanisms and clinical application显示文摘 | Chattocpadhyky S Moran RG Goldman ID | | 0，，02： | 1 |
| 3 | Pemetrexed:biochemical and cellular pharmacology,mechanisms,and clinical applications显示文摘 | Chattopadhyay S Moran RG Goldman M | 2007 | Mol Cancer Ther2007，6，2： | 1 |
| 4 | Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas 显示文摘 | Rothbart SB Racanelli AC Moran RG | 2010 | Cancer Res2010，70，10： | 1 |
| 5 | Pemetrexed: bio- chemical and cellular pharmacology, mechanisms, and clinical applications显示文摘 | Chattopadhyay S Moran RG Goldman ID | 2007 | Mol Cancer Ther2007，6，2： | 1 |
| 6 | Pemetrexed:biochemical and cellular pharmacologymechanismsand clinical applications 显示文摘 | Chattoopadhyay S Moran RG Goldman ID | 2007 | Mol Cancer2007，6，2： | 1 |
| 7 | Pemetrexed : biochemical and cellular pharmacology, mechanisms, and clinical applications 显示文摘 | Chattopadhyay S Moran RG Goldman D | 2007 | Mol Cancer Ther2007，6，2： | 1 |
| 8 | Pemetrexed:brochemical and cellular pharmacology,mechanisms,and clinical applications显示文摘 | Chattopahyay S Moran RG Goklman ID | 2007 | Mol Cancer2007，，： | 1 |
| 9 | Pemetrexed:biochemical and cellular pharmacology,mechanisms,and clinical applications显示文摘 | Chattopadhyay S Moran RG Goldman ID | 2007 | Mol Cancer Ther2007，6，2： | 1 |
| 10 | Pemetrexed:biochemical and cellular pharmacologymechanismsand clinical applications显示文摘 | Chattoopadhyay S Moran RG Goldman ID | 2007 | Mol Cancer2007，6，2： | 1 |
| 11 | Pemetrexed : biochemical and cellular pharmacology, mechanisms, and clinical applications显示文摘 | Chattopadhyay S Moran RG Goldman ID | 2007 | Mol Cancer Ther2007，6，2： | 1 |
| 12 | Pemetrexed:biochemicaland cellular pharmacology,mechanisms,and clinical applications显示文摘 | Chattopadhyay S Moran RG Goldman ID | 2007 | Mol Cancer Ther2007，6，2： | 1 |
| 13 | Pemetrexed : biochemical and cellular pharmacology, mechanisms, and clinical applications显示文摘 | Chattopadhyay S Moran RG Goldman ID | 2007 | Mol Cancer Ther2007，6，2： | 1 |
| 14 | Resistance to tomudex (ZD1694) :muhifactorial in human breast and colon carcinoma cell lines显示文摘 | Drake JC Allegra CJ Moran RG | 1996 | Biochem Pharmacol1996，51，10： | 1 |
| 15 | Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications 显示文摘 | Chattopadhyay S Moran RG Goldman ID | 2007 | Molecular Cancer Therapeutics2007，6，2： | 1 |
| 16 | Pemetrexed:biochemical and cellular pharmacology,mechanisms,and clinical applications显示文摘 | Chattopadhyay S Moran RG Goldman ID | 2007 | Mol Cancer Ther2007，6，2： | 1 |
| 17 | A moderately high fat diet promotes salt-sensitive hypertension in obese zucker rats by impairing nitric oxide production 显示文摘 | Morrison RG Mills C Moran AL | 2007 | Clin Exp Hypertens2007，29，6： | 1 |
| 18 | Collagen levels in tissues from selenium deficient ducks 显示文摘 | Brown RG Sweeny PR Moran ET Jr | 1982 | Comp Biochem Physiol A Comp Physiol1982，72，2： | 1 |
| 19 | Pemetrexed: biochemical and cellular pharmacology,mechanisms,and clinical applications 显示文摘 | Chattopadhyay S Moran RG Goldman ID | 2007 | Mol Cancer Ther2007，6，2： | 1 |
| 20 | Pemetrexed : biochemi- cal and cellular pharmacology, mechanisms, and clinical applica- tions显示文摘 | Chattopadhyay S Moran RG Goldman ID | 2007 | Mol Cancer Ther2007，6，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员